Perrigo Investors Face Jan. 16 Deadline in Securities Class Action Over Infant-Formula Disclosures

Plaintiff firms allege Perrigo understated problems and remediation needs at the Nestlé-acquired formula unit, with company updates followed by steep share declines.

Overview

A federal class action has been filed alleging violations of Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5, with lead plaintiff motions due January 16, 2026, and no class yet certified.
The complaints claim the Nestlé-derived infant formula business had significant underinvestment and manufacturing deficiencies that required capital and operational spending beyond Perrigo’s stated estimates.
Plaintiffs further allege Perrigo overstated earnings and cash flow and made misleading statements about business conditions and prospects.
Multiple firms—including Rosen, Glancy Prongay & Murray, The Schall Law Firm, DJS Law Group, and The Gross Law Firm—are soliciting shareholders on a contingency basis to seek lead-plaintiff status.
Notices cite differing proposed class periods, with some listing February 27, 2023 through November 4, 2025 and others February 27, 2025 through November 4, 2025, and reference stock drops after disclosures on Feb. 27 and May 7, 2024, Aug. 6, 2025, and a 25.2% decline on Nov. 5, 2025 following a strategic review announcement.